A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Clinical trial NCT06705140 · TERMINATED

Trial details

NCT number: NCT06705140
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

RSV Immunisation Healthy Volunteers

Start date: 2024-11-25
Primary completion: 2025-06-11
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.